Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1177/0961203310365715 http://scihub22266oqcxt.onion/10.1177/0961203310365715 20511275!ä!20511275 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Lupus 2010 ; 19 (7): 783-92 Nephropedia Template TP {{tp|p=20511275|t=2010. Clinical and molecular evidence for association of SLE with parvovirus B19 |pdf=|usr=}}{{20511275}} gab.com Text Clinical and molecular evidence for association of SLE with parvovirus B19 JO: Lupus http://www.kidney.de/pget.php?&tw=1&pmid=20511275 #FOAvip In addition to genetic and environmental factors, viruses have been suspected as causes and/or contributors to human autoimmune diseases, although direct evidence for the association is generally lacking. Parvovirus B19, the cause of Fifth disease in childhood, and possible trigger in the spectrum of autoimmune diseases in adults, has emerged as one of the central viral candidates within the last few years. In this article we propose a possible model for parvovirus B19 association with systemic lupus erythematosus (SLE). The basis for our model is the secretion of hydrolyzing anti-ssDNA autoantibodies in 30-70% of cases with SLE, which in turn can either hydrolyze viral B19 ssDNA in blood and other fluids, or intranuclear, replicated viral ssDNA after re-activation and translocation of the virus into the nucleus of the host permissive cells. Both mechanisms contribute to perpetuation and maintenance of a 'vicious cycle' with concomitant flares in SLE, and involve inevitable TLR9 sensitization and genetic switch for anti-ssDNA autoantibody production from activated B cells in individuals prone to triggering. This model strongly suggests a major potential impact upon early prevention (vaccination) and targeted therapy of this subclass within the SLE spectrum of diseases. Incorporated in this new concept is an innovative idea for developing the tool for more precise (individualized) diagnosis, prevention, and therapy. Twit Text FOAVip Clinical and molecular evidence for association of SLE with parvovirus B19 ????Lupus http://www.kidney.de/pget.php?&tw=1&pmid=20511275 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=20511275 #FOAvip English Wikipedia <ref>{{Cite pmid|20511275}}</ref> Clinical and molecular evidence for association of SLE with parvovirus B19 #MMPMID20511275 Pavlovic M; Kats A; Cavallo M; Shoenfeld Y Lupus 2010[Jun]; 19 (7): 783-92 PMID20511275show ga In addition to genetic and environmental factors, viruses have been suspected as causes and/or contributors to human autoimmune diseases, although direct evidence for the association is generally lacking. Parvovirus B19, the cause of Fifth disease in childhood, and possible trigger in the spectrum of autoimmune diseases in adults, has emerged as one of the central viral candidates within the last few years. In this article we propose a possible model for parvovirus B19 association with systemic lupus erythematosus (SLE). The basis for our model is the secretion of hydrolyzing anti-ssDNA autoantibodies in 30-70% of cases with SLE, which in turn can either hydrolyze viral B19 ssDNA in blood and other fluids, or intranuclear, replicated viral ssDNA after re-activation and translocation of the virus into the nucleus of the host permissive cells. Both mechanisms contribute to perpetuation and maintenance of a 'vicious cycle' with concomitant flares in SLE, and involve inevitable TLR9 sensitization and genetic switch for anti-ssDNA autoantibody production from activated B cells in individuals prone to triggering. This model strongly suggests a major potential impact upon early prevention (vaccination) and targeted therapy of this subclass within the SLE spectrum of diseases. Incorporated in this new concept is an innovative idea for developing the tool for more precise (individualized) diagnosis, prevention, and therapy. |Adult[MESH] |Animals[MESH] |Autoantibodies/blood[MESH] |Child[MESH] |DNA, Single-Stranded/immunology/metabolism[MESH] |DNA, Viral/immunology/metabolism[MESH] |Humans[MESH] |Lupus Erythematosus, Systemic/*virology[MESH] |Parvoviridae Infections/*complications/immunology/virology[MESH] |Parvovirus B19, Human/immunology/*isolation & purification[MESH] |Toll-Like Receptor 9/immunology[MESH]Clinical and molecular evidence for association of SLE with parvovirus(epmc).pdf DeepDyve Pubget Overpricing